Decreased endothelial nitric oxide, systemic oxidative stress, and increased sympathetic modulation contribute to hypertension in obese rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 306, Issue 10, 2014, Pages

  da Cunha, Natalia Veronez ^a   Pinge Filho, Phileno ^a   Panis, Carolina ^a   Silva, Bruno Rodrigues ^b   Pernomian, Laena ^b   Grando, Marcella Daruge ^b   Cecchini, Rubens ^a   Bendhack, Lusiane Maria ^b   Martins Pinge, Marli Cardoso ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Autonomic; Endothelium; Monosodium glutamate; Nitric oxide synthase

Indexed keywords

ACETYLCHOLINE; GLUTAMATE SODIUM; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE; SUPEROXIDE;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTERIAL PRESSURE; ARTERY CATHETERIZATION; ARTICLE; BLOOD PRESSURE VARIABILITY; BLOOD VESSEL REACTIVITY; BODY WEIGHT; CELL ISOLATION; CHEMOLUMINESCENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; FLOW CYTOMETRY; FLUORESCENCE; HEART RATE; HYPERTENSION; LIPID PEROXIDATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SYMPATHETIC MODULATION; VASCULAR RING;

AUTONOMIC; ENDOTHELIUM; MONOSODIUM GLUTAMATE; NITRIC OXIDE SYNTHASE;

ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HEART RATE; HYPERTENSION; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OBESITY; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SODIUM GLUTAMATE; SYMPATHETIC NERVOUS SYSTEM;

EID: 84900553179     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00520.2013     Document Type: Article

References (64)

1. Aneja A, El-Atat F, McFarlane SI, Sowers JR. Hypertension and obesity. Recent Prog Horm Res 59: 169-205, 2004.
2. Balbo SL, Mathias PC, Bonfleur ML, Alves HF, Siroti FJ, Monteiro OG, Ribeiro FB, Souza AC. Vagotomy reduces obesity in MSG-treated rats. Res Commun Mol Pathol Pharmacol 108: 291-296, 2000.
3. Blanc J, Ponchon P, Laude D, Elghozi JL, Jover B. Blood pressure variability in established L-NAME hypertension in rats. J Hypertens 17: 1527-1534, 1999.
4. Bonaventura D, Lunardi CN, Rodrigues GJ, Neto MA, Vercesi JA, de Lima RG, da Silva RS, Bendhack LM. Endothelium negatively modulates the vascular relaxation induced by nitric oxide donor, due to uncoupling NO synthase. J Inorg Biochem 103: 1366-1374, 2009.
5. Campese VM, Ye S, Zhong H, Yanamadala V, Ye Z, Chiu J. Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity. Am J Physiol Heart Circ Physiol 287: H695-H703, 2004.
6. Carlson SH, Shelton J, White CR, Wyss JM. Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats. Hypertension 35: 403-408, 2000.
7. Cunha NV, de Abreu SB, Panis C, Grassiolli S, Guarnier FA, Cecchini R, Mazzuco TL, Pinge-Filho P, Martins-Pinge MC. Cox-2 inhibition attenuates cardiovascular and inflammatory aspects in monosodium glutamate-induced obese rats. Life Sci 87: 375-381, 2010.
8. da Cunha NV, Pinge-Filho P, Barbosa Neto O, Grassiolli S, Martins-Pinge MC. COX-2 inhibition does not reverse the increased sympathetic modulation in MSG obese rats. Auton Neurosci 165: 201-204, 2011.
9. da Silva AA, do Carmo J, Dubinion J, Hall JE. The role of the sympathetic nervous system in obesity-related hypertension. Curr Hypertens Rep 11: 206-211, 2009.
10. da Silva Mattos AM, Xavier CH, Karlen-Amarante M, da Cunha NV, Fontes MA, Martins-Pinge MC. Renal sympathetic nerve activity is increased in monosodium glutamate induced hyperadipose rats. Neurosci Lett 522: 118-122, 2012.
11. Danson EJ, Paterson DJ. Cardiac neurobiology of nitric oxide synthases. Ann NY Acad Sci 1047: 183-196, 2005.
12. Dawson R, Pelleymounter MA, Millard WJ, Liu S, Eppler B. Attenuation of leptin-mediated effects by monosodium glutamate-induced arcuate nucleus damage. Am J Physiol Endocrinol Metab 273: E202-E206, 1997.
13. de Abreu SB, Lenhard A, Mehanna A, de Souza HC, Correa FM, Hasser EM, Martins-Pinge MC. Role of paraventricular nucleus in exercise training-induced autonomic modulation in conscious rats. Auton Neurosci 148: 28-35, 2009.
14. de Carvalho Papa P, Vargas AM, da Silva JL, Nunes MT, Machado UF. GLUT4 protein is differently modulated during development of obesity in monosodium glutamate-treated mice. Life Sci 71: 1917-1928, 2002.
15. de Freitas Mathias PC, Grassiolli S, Rocha DN, Scomparin DX, Gravena C. Transplantation of pancreatic islets from hypothalamic obese rats corrects hyperglycemia of diabetic rats. Transplant Proc 39: 193-195, 2007.
16. De Iuliis GN, Wingate JK, Koppers AJ, McLaughlin EA, Aitken RJ. Definitive evidence for the nonmitochondrial production of superoxide anion by human spermatozoa. J Clin Endocrinol Metab 91: 1968-1975, 2006.
17. DeLisser HM, Christofidou-Solomidou M, Strieter RM, Burdick MD, Robinson CS, Wexler RS, Kerr JS, Garlanda C, Merwin JR, Madri JA, Albelda SM. Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol 151: 671-677, 1997.
18. Dolnikoff M, Martín-Hidalgo A, Machado UF, Lima FB, Herrera E. Decreased lipolysis and enhanced glycerol and glucose utilization by adipose tissue prior to development of obesity in monosodium glutamate (MSG) treated-rats. Int J Obes Relat Metab Disord 25: 426-433, 2001.
19. Dusse LMS, Vieira LM, Carvalho MG. Revisão sobre óxido nítrico. J Bras Patol Med Lab 39: 343-350, 2003.
20. Elmarakby AA, Imig JD. Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diethypertensive rats. Clin Sci 118: 291-301, 2010.
21. Fernández-Sánchez A, Madrigal-Santillán E, Bautista M, Esquivel-Soto J, Morales-González A, Esquivel-Chirino C, Durante-Montiel I, Sánchez-Rivera G, Valadez-Vega C, Morales-González JA. Inflammation, oxidative stress, obesity. Int J Mol Sci 12: 3117-3132, 2011.
22. Förstermann U, Münzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113: 1708-1714, 2006.
23. Grassi G. Sympathetic neural activity in hypertension and related diseases. Am J Hypertens 23: 1052-1060, 2010.
24. Hill JO. Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocr Rev 27: 750-761, 2006.
25. Hirooka Y, Kishi T, Sakai K, Takeshita A, Sunagawa K. Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension. Am J Physiol Regul Integr Comp Physiol 300: R818-R826, 2011.
26. Hotamisligil GS. Inflammation and metabolic disorders. Nature 444: 860-867, 2006.
27. Jonk AM, Houben AJ, de Jongh RT, Serné EH, Schaper NC, Stehouwer CD. Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Physiology 22: 252-260, 2007.
28. Karlen-Amarante M, da Cunha NV, de Andrade O, de Souza HC, Martins-Pinge MC. Altered baroreflex and autonomic modulation in monosodium glutamate-induced hyperadipose rats. Metabolism 61: 1435-1442, 2012.
29. Kizer JS, Nemeroff CB, Youngblood WW. Neurotoxic amino acids and structurally related analogs. Pharmacol Rev 29: 301-318, 1977.
30. Koeners MP, Braam B, Joles JA. Perinatal inhibition of NF-kappaB has long-term antihypertensive effects in spontaneously hypertensive rats. J Hypertens 29: 1160-1166, 2011.
31. Kojima H, Nakatsubo N, Kikuchi K, Urano Y, Higuchi T, Tanaka J, Kudo Y, Nagano T. Direct evidence of NO production in rat hippocampus and cortex using a new fluorescent indicator: DAF-2 DA. Neuroreport 9: 3345-3348, 1998.
32. Könner AC, Klöckener T, Brüning JC. Control of energy homeostasis by insulin and leptin: targeting the arcuate nucleus and beyond. Physiol Behav 97: 632-638, 2009.
33. Lambert GW, Straznicky NE, Lambert EA, Dixon JB, Schlaich MP. Sympathetic nervous activation in obesity and the metabolic syndromecauses, consequences and therapeutic implications. Pharmacol Ther 126: 159-172, 2010.
34. Lobato NS, Filgueira FP, Akamine EH, Davel AP, Rossoni LV, Tostes RC, Carvalho MH, Fortes ZB. Obesity induced by neonatal treatment with monosodium glutamate impairs microvascular reactivity in adult rats: role of NO and prostanoids. Nutr Metab Cardiovasc Dis 21: 808-816, 2011.
35. Lobato NS, Filgueira FP, Hagihara GN, Akamine EH, Pariz JR, Tostes RC, Carvalho MH, Fortes ZB. Improvement of metabolic parameters and vascular function by metformin in obese non-diabetic rats. Life Sci 90: 228-235, 2012.
36. Lopes HF. Hipertensão e inflamação: papel da obesidade. Rev Bras Hipertens 14: 239-244, 2007.
37. Macarthur H, Westfall TC, Wilken GH. Oxidative stress attenuates NO-induced modulation of sympathetic neurotransmission in the mesenteric arterial bed of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 294: H183-H189, 2008.
38. Macho L, Ficková M, Jezová Zórad S. Late effects of postnatal administration of monosodium glutamate on insulin action in adult rats. Physiol Res 49: S79-S85, 2000.
39. Maletínská L, Toma RS, Pirnik Z, Kiss A, Slaninová J, Haluzík M, Zelezná B. Effect of cholecystokinin on feeding is attenuated in monosodium glutamate obese mice. Regul Pept 136: 58-63, 2006.
40. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 84: 482-492, 1991.
41. Martins-Pinge MC, Becker LK, Garcia MR, Zoccal DB, Neto RV, Basso LS, de Souza HC, Lopes OU. Attenuated pressor responses to amino acids in the rostral ventrolateral medulla after swimming training in conscious rats. Auton Neurosci 122: 21-28, 2005.
42. Mathieu P, Poirier P, Pibarot P, Lemieux I, Després JP. Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension 53: 577-584, 2009.
43. Mehanna A, Vitorino DC, Panis C, Blanco EE, Pinge-Filho P, Martins-Pinge MC. Cardiovascular and pulmonary effects of NOS inhibition in endotoxemic conscious rats subjected to swimming training. Life Sci 81: 1301-1308, 2007.
44. Mendizábal Y, Llorens S, Nava E. Hypertension in metabolic syndrome: vascular pathophysiology. Int J Hypertens 2013: 1-15, 2013.
45. Moss MB, Brunini TM, Soares De Moura R, Novaes Malagris LE, Roberts NB, Ellory JC, Mann GE, Mendes Ribeiro AC. Diminished L-arginine bioavailability in hypertension. Clin Sci 107: 391-397l, 2004.
46. Oliveira-Sales EB, Nishi EE, Carillo BA, Boim MA, Dolnikoff MS, Bergamaschi CT, Campos RR. Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension. Am J Hypertens 22: 484-492, 2009.
47. Olney JW. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164: 719-721, 1969.
48. Perelló M, Gaillard RC, Chisari A, Spinedi E. Adrenal enucleation in MSG-damaged hyperleptinemic male rats transiently restores adrenal sensitivity to leptin. Neuroendocrinology 78: 176-184, 2003.
49. Rahmouni K, Correia ML, Haynes WG, Mark AL. Obesity-associated hypertension: new insights into mechanisms. Hypertension 45: 9-14, 2005.
50. Rana JS, Nieuwdorp M, Jukema JW, Kastelein JJ. Cardiovascular metabolic syndrome-an interplay of, obesity, inflammation, diabetes and coronary heart disease. Diabetes Obes Metab 9: 218-232, 2007.
51. Rodríguez A, Becerril S, Valentí V, Ramírez B, Martín M, Méndez-Giménez L, Lancha A, del Sol Calderón P, Catalán V, Burrell MA, Gómez-Ambrosi J, Frühbeck G. Sleeve gastrectomy reduces blood pressure in obese (fa/fa) Zucker rats. Obes Surg 22: 309-315, 2012.
52. Romagnano MA, Pilcher WH, Bennett-Clarke C, Chafel TL, Joseph SA. Distribution of somatostatin in the mouse brain: effects of neonatal MSG treatment. Brain Res 234: 387-398, 1982.
53. Rubini R, Porta A, Baselli G, Cerutti S, Paro M. Power spectrum analysis of cardiovascular variability monitored by telemetry in conscious unrestrained rats. J Auton Nerv Syst 45: 181-190, 1993.
54. Sarafidis PA. Obesity, insulin resistance and kidney disease risk: insights into the relationship. Curr Opin Nephrol Hypertens 17: 450-456, 2008.
55. Shibao C, Gamboa A, Diedrich A, Ertl AC, Chen KY, Byrne DW, Farley G, Paranjape SY, Davis SN, Biaggioni I. Autonomic contribution to blood pressure and metabolism in obesity. Hypertension 49: 27-33, 2007.
56. Souza HC, Ballejo G, Salgado MC, Da Silva VJ, Salgado HC. Cardiac sympathetic overactivity and decreased baroreflex sensitivity in L-NAME hypertensive rats. Am J Physiol Heart Circ Physiol 280: H844-H850, 2001.
57. Souza HC, De Araújo JE, Martins-Pinge MC, Cozza IC, Martins-Dias DP. Nitric oxide synthesis blockade reduced the baroreflex sensitivity in trained rats. Auton Neurosci 150: 38-44, 2009.
58. Souza HC, Martins-Pinge MC, Dias da Silva VJ, Borghi-Silva A, Gastaldi AC, Blanco JH, Tezini GC. Heart rate and arterial pressure variability in the experimental renovascular hypertension model in rats. Auton Neurosci 139: 38-45, 2008.
59. Task Force of the European Society of Cardiology, and the North American Society of Pacing and Electrophysiology. Heart rate variability Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17: 354-381, 1996.
60. Tokarev D, Jezová D. Effect of nitric oxide inhibition on blood pressure and corticosterone responses in adult rats neonatally treated with glutamate. Physiol Res 1: S87-S94, 2000.
61. Valerio A, Cardile A, Cozzi V, Bracale R, Tedesco L, Pisconti A, Palomba L, Cantoni O, Clementi E, Moncada S, Carruba MO, Nisoli E. TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J Clin Invest 116: 2791-2798, 2006.
62. Wang DS, Xie HH, Shen FM, Cai GJ, Su DF. Blood pressure variability, cardiac baroreflex sensitivity and organ damage in experimentally hypertensive rats. Clin Exp Pharmacol Physiol 32: 545-552, 2005.
63. Zelezná B, Maixnerová J, Matysková R, Haugvicová R, Blokesová D, Maletínská L. Anorexigenic effect of cholecystokinin is lost but that of CART (Cocaine and Amphetamine Regulated Transcript) peptide is preserved in monosodium glutamate obese mice. Physiol Res 58: 717-723, 2008.
64. Zimiani K, Guarnier FA, Miranda HC, Watanabe MA, Cecchini R. Nitric oxide mediated oxidative stress injury in rat skeletal muscle subjected to ischemia/reperfusion as evaluated by chemiluminescence. Nitric Oxide 13: 196-203, 2005.